An unmet need: Pancreatic beta cell replacement
Diabetes mellitus (DM) is a growing public health concern in South Africa (SA) and poses a substantial economic burden on healthcare globally. A century has passed since the discovery of insulin, and despite advances in diabetes management, exogenous insulin remains a primary treatment for type...
Saved in:
Main Authors: | F Mohamed, C Adams, B Mansfield |
---|---|
Format: | Article |
Language: | English |
Published: |
South African Medical Association
2024-04-01
|
Series: | South African Medical Journal |
Subjects: | |
Online Access: | https://samajournals.co.za/index.php/samj/article/view/1249 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements and Challenges in Immune Protection Strategies for Islet Transplantation
by: Xue Wang, et al.
Published: (2025-01-01) -
Enhanced dynorphin expression and secretion in pancreatic beta-cells under hyperglycemic conditions
by: Miranda Movahed, et al.
Published: (2025-02-01) -
LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype
by: Nadia Cobo‐Vuilleumier, et al.
Published: (2024-12-01) -
FMT reduces systemic inflammatory response in severe acute pancreatitis by increasing the abundance of intestinal Bifidobacteria and fecal bacteria
by: Yanning Mao, et al.
Published: (2024-12-01) -
Generalizability of machine learning models for diabetes detection a study with nordic islet transplant and PIMA datasets
by: Dinesh Chellappan, et al.
Published: (2025-02-01)